Solitaire支架取栓治疗急性脑血管闭塞的临床疗效及安全性

发布时间：2018-01-08 13:07

  本文关键词：Solitaire支架取栓治疗急性脑血管闭塞的临床疗效及安全性　出处：《中国实用神经疾病杂志》2016年23期 　论文类型：期刊论文

  更多相关文章： Solitaire 急性脑血管闭塞 血管内 机械性治疗

【摘要】：目的探讨Solitaire支架取栓治疗急性脑内血管闭塞的临床效果及安全性。方法对2015-01—2016-03我院收治的60例急性脑梗死患者均采用Solitaire支架血管内取栓治疗,分析其治疗效果及手术并发症。结果 60例患者均顺利完成Solitaire支架血管内的机械性治疗,再通急性闭塞的血管,治疗后1个月、2个月及3个月美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分、改良Rankin量表(modified Rankin scale,mRS)评分均较治疗前显著降低(P0.05)。结论 Solitaire支架对急性脑血管闭塞的取栓治疗安全且疗效显著,尤其对前循环动脉闭塞患者具有较好的再通效果,可有效改善患者的神经功能,提高生存质量,值得临床推广应用。
[Abstract]:Objective to investigate the clinical effect and safety of Solitaire stent thrombectomy in the treatment of acute cerebral vascular occlusion. Methods 60 patients with acute cerebral infarction were treated from 2015-01-2016-03 in our hospital. All patients were treated with Solitaire stent endovascular thrombectomy. Results 60 cases of Solitaire stents successfully completed the mechanical treatment of intravascular, re-opened the acute occlusion of blood vessels, 1 month after treatment. The National Institutes of Health Stroke Scale was included in the National Institute of Health Stroke scale for 2 and 3 months. NIHSS score, modified Rankin scale, modified Rankin scale. The scores of mRSs were significantly lower than those before treatment. Conclusion Solitaire stent is safe and effective in the treatment of acute cerebral vascular occlusion. Especially for the patients with anterior circulatory artery occlusion, it has better recanalization effect, can effectively improve the neurological function of patients, improve the quality of life, and is worthy of clinical application.
【作者单位】： 山东聊城市第三人民医院;
【分类号】：R743.3
【正文快照】： 急性脑血管闭塞是一种常见的脑血管病,致死率、致残率均较高,多为中老年人,如不积极治疗其预后较差,严重影响人们的生命健康和生活质量[1]。目前认为,治疗原则以恢复其脑动脉血管的血液流动为主[2],即在有效时间窗内尽早进行血管内机械性治疗,去除血栓使急性闭塞的脑血管再通，

本文编号：1397213